TNF and inflammatory bowel disease: Taken together, these data combined with the previously observed accelerated decline of antibody titers under anti-TNF therapies [17] sustain an individualized vaccination schedule with (repeated) booster vaccination to improve and extend immune responses in IBD patients receiving anti-TNF therapies.